<?xml version="1.0" encoding="UTF-8"?>
<ref id="B49-pharmaceuticals-13-00303">
 <label>49.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jahanban-Esfahlan</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Seidi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Manjili</surname>
    <given-names>M.H.</given-names>
   </name>
   <name>
    <surname>Jahanban-Esfahlan</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Javaheri</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Zare</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Tumor Cell Dormancy: Threat or Opportunity in the Fight against Cancer</article-title>
  <source>Cancers</source>
  <year>2019</year>
  <volume>11</volume>
  <elocation-id>1207</elocation-id>
  <pub-id pub-id-type="doi">10.3390/cancers11081207</pub-id>
  <?supplied-pmid 31430951?>
  <pub-id pub-id-type="pmid">31430951</pub-id>
 </element-citation>
</ref>
